One year has passed since Joe Biden urged MIS2016 attendees to act with the “urgency of now” in the global fight against cancer. He laid out the need for radical collaborations at the federal level that could enable data sharing, clinical trial redesign, the use of supercomputers, and precision medicine to take this fight to a new level.
Yet, a lot has changed in 12 months: A New administration. New budgets. New diagnostics, and new therapies. And yet cancer remains, killing nearly 600,000 Americans per year.
For now, cancer remains one of the few bipartisan issues in Congress. To keep collaborations strong, and the momentum going, conversation is needed to reinforce the mission. This conversation is rooted in two important questions (1) is curing cancer a realistic goal? And (2) can the government really play a leading role in this fight?
The answers are never simple. For example, our ability to classify and target specific cancer is getting more complex as we dig deeper into each tumor’s makeup. While gene editing and therapies are showing promise, there is also a new fear of going too far. And one particular question always lurks: can the government guarantee the resources and resolve required for an enduring battle with such a relentless foe?
MIS2017 will look to re-inject the urgency
of to defeat cancer by tackling these questions and exploring the tactics laid out by Vice President Joe Biden with leaders from across the Federal Government. On Tuesday, October 24 at 9:45, attendees will hear a live conversation between Dr. David Shulkin, Secretary of the VA; Anna Abrams, Deputy Commissioner for Policy, Planning, Legislation & Analysis of the FDA, Dr. Eric Green, the Director of the National Human Genomic Research Institute at NIH; and Dr. Brian Bolwell, Chair of Cleveland Clinic’s Taussig Cancer Institute. The conversation will be moderated by Dr. Reed Tuckson.
Join us, by registering for MIS2017 today.